Hemoccult Ict | Clia Waived Rapid Testing

Beckman Coulter, Inc.

Have Company Representative Contact Me

Send More Information

Send Pricing

Would like a Demo

Would like to Order

Hemoccult® ICT is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult® ICT is an ideal colorectal cancer (CRC) screening tool. Higher specificity reduces the number of false positive test results, thus reducing the number of needless colonoscopies. Hemoccult® ICT is patient friendly, as there are no diet or drug restrictions for patients, which helps increase patient return rate.

Hemoccult® ICT

Hemoccult® ICT is the latest and most advanced fecal occult blood test (FOBT) in the Hemoccult® product line. An immunochemical FOBT (iFOBT) with high specificity and sensitivity, Hemoccult® ICT is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult® ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. Safe and non-invasive, Hemoccult® ICT is very patient friendly, as there are no diet or drug restrictions for patients to follow while they are using it, which helps increase patient compliance.

Product Features

Better Healthcare

Clinically proven immunochemical FOBT
Human hemoglobin specific means fewer false positives
High sensitivity and specificity
Detects lower GI bleeding

Improved Compliance

No diet or drug restrictions
Safe, non-invasive
CLIA waived with clear, readable results

Note: Not all products are available in all countries.